Company intelligence / Profile preview
Zhang Xi-chun
- Ownership
- Private
- Development stage
- Other
Overview
Hebei Zhang Xichun Pharmaceutical is a Chinese pharmaceutical company specializing in the development, production, and sale of Traditional Chinese Medicine (TCM). Named after the renowned TCM physician Zhang Xichun, the company focuses on modernizing classical prescriptions from his seminal work, Records of Heart-felt Experiences in Medicine with Reference to the West. Its product portfolio includes various dosage forms such as capsules, granules, and tablets targeting respiratory, digestive, and cardiovascular health. The company operates primarily within the Chinese domestic market, leveraging the historical prestige of its namesake to market standardized TCM formulations.
- Therapeutic areas
- CardiovascularPulmonologyWomen's HealthGastroenterology
- Modalities
- Small moleculeNatural product
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Zhang Xi-chun.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhang Xi-chun.